Cargando…
Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report
BACKGROUND: Multiple sclerosis is a relatively rare disease, and complications of multiple sclerosis and rheumatoid arthritis are much rarer. Since anti-tumor necrosis factor therapy increases exacerbations of multiple sclerosis, complications of demyelinating diseases contraindicate anti-tumor necr...
Autores principales: | Sato, Hiroe, Kobayashi, Daisuke, Abe, Asami, Ito, Satoshi, Ishikawa, Hajime, Nakazono, Kiyoshi, Murasawa, Akira, Kuroda, Takeshi, Nakano, Masaaki, Narita, Ichiei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171561/ https://www.ncbi.nlm.nih.gov/pubmed/25216562 http://dx.doi.org/10.1186/1756-0500-7-641 |
Ejemplares similares
-
The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis
por: Hasegawa, Eriko, et al.
Publicado: (2023) -
Effectiveness and Safety of Golimumab for Patients ≥75 Years Old with Rheumatoid Arthritis
por: Kurosawa, Yoichi, et al.
Publicado: (2022) -
An Analysis of the Neuropathic Pain Components in Rheumatoid Arthritis Patients
por: Ito, Satoshi, et al.
Publicado: (2017) -
Interleukin‐6 receptor inhibitor tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors
por: Kobayashi, Tetsuo, et al.
Publicado: (2015) -
An Analysis of the Biological Disease-modifying Antirheumatic Drug-free Condition of Adalimumab-treated Rheumatoid Arthritis Patients
por: Ito, Satoshi, et al.
Publicado: (2018)